Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML

Original Article

A.E. Perl, G. Martinelli, J.E. Cortes, A. Neubauer, E. Berman, S. Paolini, P. Montesinos, M.R. Baer, R.A. Larson, C. Ustun, F. Fabbiano, H.P. Erba, A.D. Stasi, R. Stuart, R. Olin, M. Kasner, F. Ciceri, W.-C. Chou, N. Podoltsev, C. Recher, H. Yokoyama, N. Hosono, S.-S. Yoon, J.-H. Lee, T. Pardee, A.T. Fathi, C. Liu, N. Hasabou, X. Liu, E. Bahceci, and M.J. Levis

N Engl J Med 2019;381:1728-1740

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
10/30/2019
Course expires: 
10/31/2021

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Course closed

This course closed on Sunday, October 31, 2021 - 11:59pm.